Guided Anti-P2Y12 Therapy in Patients Undergoing Percutaneous Coronary Intervention-Reference-Cited by-同舟云学术

Guided Anti-P2Y12 Therapy in Patients Undergoing Percutaneous Coronary Intervention

Published:2023-11-22 Issue: Volume: Page:
ISSN:0340-6245
Container-title:Thrombosis and Haemostasis
language:en
Short-container-title:Thromb Haemost

Author:

Cattaneo Marco¹²^ORCID,Squizzato Alessandro³^ORCID,Birocchi Simone¹,Podda Gian Marco¹^ORCID

Affiliation:

1. Divisione di Medicina Generale II, ASST Santi Paolo e Carlo, Dipartimento di Scienze della Salute, Università degli Studi di Milano, Milan, Italy

2. Fondazione Arianna Anticoagulazione, Bologna, Italy

3. Research Center on Thromboembolic Disorders and Antithrombotic Therapies, ASST Lariana, University of Insubria, Como, Italy

Publisher

Georg Thieme Verlag KG

Subject

Hematology

Link

http://www.thieme-connect.de/products/ejournals/pdf/10.1055/a-2216-5263.pdf

Reference25 articles.

1. Strategies for tailored antiplatelet therapy after percutaneous coronary intervention: unraveling complexities, embracing nuances;D Landolina;Thromb Haemost,2023

2. Guided anti-P2Y12 therapy in patients undergoing PCI: three systematic reviews with meta-analyses of randomized controlled trials with homogeneous design;S Birocchi;Thromb Haemost,2023

3. Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis;M Galli;Lancet,2021

4. Does individualized guided selection of antiplatelet therapy improve outcomes after percutaneous coronary intervention? A systematic review and meta-analysis;N Yamani;Ann Med Surg (Lond),2022

5. Why have studies of tailored anti-platelet therapy failed so far?;J M Siller-Matula;Thromb Haemost,2013